Heska Corporation (HSKA) News
Filter HSKA News Items
HSKA News Results
|Loading, please wait...|
Latest HSKA News From Around the Web
Below are the latest news stories about HESKA CORP that investors may wish to consider to help them evaluate HSKA as an investment opportunity.
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund underperformed the Russell 2000 Growth Index. The Health Care and Energy sectors contributed to the fund’s relative performance in the quarter, […]
Heska (HSKA) delivered earnings and revenue surprises of -46.88% and 7.10%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, reported financial results for its first quarter ended March 31, 2023.
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announces its 2023 Annual Meeting of Stockholders. The virtual event is scheduled for 9 a.m. MT / 11 a.m. ET on Wednesday, May 3, 2023. Stockholders of record as of March 6, 2023, are entitled to notice of, participate in and vote at, the annual meeting. All stockholders are encouraged to vote on the proposed matters before the Annual Meeting by proxy a
The three-year returns have been strong for Heska (NASDAQ:HSKA) shareholders despite underlying losses increasing
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
The Dow Jones Industrial Average is up 146 points midday to kick off the second quarter, while the S&P 500 Index inches lower, and the Nasdaq Composite sits firmly in the red.
Mars, the fourth-largest privately held company in the U.S., has agreed to buy the pet diagnostics and specialty products company Heska (NASDAQ: HSKA) for $120 per share. This buyout agreement represents a 23% premium relative to Heska's closing price last Friday. Through this deal, Mars will gain Heska's rapidly growing suite of pet diagnostics products, which are quickly becoming an integral part of the veteinary practices across a wide range of geographies.
Mars Inc is buying veterinary equipment firm Heska Corp in a $1.3-billion deal as the maker of Pedigree dog food looks to expand its animal diagnostics business. In a joint statement issued on Monday, Mars said it would pay $120 per share to Heska's shareholders, which is a premium of 22.9% over its last close. Shares of Heska were up 19.8% to $116.6, in early morning trading.
Mars, Incorporated ("Mars"), and Heska Corporation (NASDAQ: HSKA) ("Heska") today announced that they have entered into a definitive agreement under which Mars will acquire Heska, a global provider of advanced veterinary diagnostic and specialty products for $120.00 per share. The transaction price represents a premium of approximately 38% over Heska's 60-calendar day volume weighted average price and a premium of approximately 23% over Heska's closing stock price as of March 31, 2023. The agree
By Scott Kanowsky